Hypertension and kidney protection in the elderly: what is the evidence in 2007? (Q36814866)

16 August 2017

1 reference

title

Hypertension and kidney protection in the elderly: what is the evidence in 2007? (English)

1 reference

16 August 2017

Robert D Lindeman

1

1 reference

16 August 2017

9 May 2007

1 reference

International Urology and Nephrology

16 August 2017

1 reference

16 August 2017

39

1 reference

16 August 2017

2

1 reference

16 August 2017

669-678

1 reference

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

16 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-007-9207-9

The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-007-9207-9

Embracing complexity: A consideration of hypertension in the very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-007-9207-9

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-007-9207-9

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients

21 January 2018

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Rapid nongenomic effects of aldosterone on the renal vasculature in humans

1 reference

12 December 2020

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

12 December 2020

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate

1 reference

12 December 2020

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes

1 reference

12 December 2020

Pathophysiology of hypertensive renal damage: implications for therapy

1 reference

12 December 2020

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

12 December 2020

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

12 December 2020

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

12 December 2020

How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?

1 reference

12 December 2020

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

12 December 2020

Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences

1 reference

12 December 2020

Long-term effects of antihypertensive agents on proteinuria and renal function

1 reference

12 December 2020

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

12 December 2020

Results of the pilot study for the Hypertension in the Very Elderly Trial

1 reference

12 December 2020

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

1 reference

12 December 2020

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

1 reference

12 December 2020

In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia

1 reference

12 December 2020

ACE inhibitors versus diuretics: ALLHAT versus ANBP2

1 reference

12 December 2020

Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications

1 reference

12 December 2020

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

12 December 2020

Halting the progression of chronic nephropathy.

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis

1 reference

12 December 2020

Study of Heart and Renal Protection (SHARP)

1 reference

12 December 2020

Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group

1 reference

12 December 2020

Renal protection in hypertensive patients: selection of antihypertensive therapy

1 reference

12 December 2020

Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

12 December 2020

Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population

1 reference

12 December 2020

Systolic hypertension in older persons

1 reference

12 December 2020

Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial

1 reference

12 December 2020

Rosiglitazone reduces urinary albumin excretion in type II diabetes

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH

1 reference

12 December 2020

Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.

1 reference

12 December 2020

Effect of pravastatin in people with diabetes and chronic kidney disease

1 reference

12 December 2020

Aldosterone antagonism in chronic kidney disease

1 reference

12 December 2020

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function.

1 reference

12 December 2020

Aldosterone in the development and progression of renal injury

1 reference

12 December 2020

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

1 reference

12 December 2020

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

1 reference

12 December 2020

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

12 December 2020

Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

1 reference

12 December 2020

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

12 December 2020

10.1007/S11255-007-9207-9

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17487566